Go to the list of all blogs
Abhoy Sarkar's Avatar
published in Blogs
Feb 16, 2026
Quantum Computing Inc. (QUBT) Stock Analysis: Photonics Strategy Redefines Growth Outlook

Quantum Computing Inc. (QUBT) Stock Analysis: Photonics Strategy Redefines Growth Outlook

Key Takeaways

  • Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities.

  • Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.

  • Analysts maintain an Overweight consensus with an average price target of $18, reflecting confidence in QUBT’s strategic direction.

  • A January 12 stalking horse bid announcement triggered sharp price gains, underscoring strong investor interest in acquisition-driven growth.

  • Broader enthusiasm for quantum technologies continues to support sentiment, though execution and integration risks remain central.

Market Snapshot

Quantum Computing Inc. (QUBT) has experienced wide price swings in recent weeks as investors react to strategic developments in photonics and quantum optics. Shares have oscillated between highs near $13 and lows around $7.80, with trading volumes far exceeding historical averages. This volatility highlights the market’s sensitivity to merger activity and the broader momentum surrounding quantum computing. With a market capitalization above $2 billion, QUBT stands out among emerging quantum-focused companies, as integration progress and analyst optimism shape near-term trading dynamics.

Key Developments Driving Share Performance

QUBT has been at the center of heightened market attention over the past month, driven primarily by acquisition-related catalysts. The most significant development was the completion of its $110 million all-cash purchase of Luminar Semiconductor, Inc. on February 2, 2026. Luminar Semiconductor, formerly part of Luminar Technologies, contributes expertise in lasers, detectors, advanced packaging, and semiconductor manufacturing. These capabilities complement QUBT’s thin-film lithium niobate (TFLN) photonics platform and move the company closer to full vertical integration.

By controlling the photonics signal chain—from light generation to detection—QUBT aims to accelerate the development of compact, scalable quantum systems suitable for mass production. The acquisition also brings near-term revenue visibility through Luminar Semiconductor’s existing aerospace, defense, and industrial contracts, aligning with U.S. reshoring efforts and national security priorities. Funding for the transaction was supported by prior capital raises, mitigating immediate balance-sheet strain.

Momentum built earlier when QUBT announced on January 12 that it had been named stalking horse bidder for select Luminar LiDAR assets, with an indicative bid of approximately $22 million, subject to auction. The announcement sparked an immediate rally, with shares closing at $12.11 on nearly 15 million shares traded—well above average volume. Optimism carried the stock to a mid-January peak of $12.70 before profit-taking set in, leading to a pullback toward the $9 level. Sustained daily volumes above 10 million shares reflected continued investor engagement.

Analyst coverage reinforced interest during this period. Rosenblatt initiated coverage with a Buy rating and a $22 price target, while Ascendiant Capital reiterated bullish views with targets as high as $25. Lake Street Capital reduced its target to $16 from $24 but maintained a Buy rating. Overall, six analysts currently rate the stock Overweight, with an average target of $18, signaling expectations for meaningful upside despite near-term volatility.

Following the February 2 acquisition close, QUBT shares initially consolidated around $9.34 before rebounding sharply, rising more than 20% in early February on volume exceeding 20 million shares. A brief dip to $7.81 reflected post-deal digestion, but renewed buying suggested confidence in the integration thesis. Earlier Q3 2025 earnings, reported in November, included a surprise $0.01 per-share profit, providing a supportive backdrop, though recent price action has been driven primarily by M&A developments. Sector-wide enthusiasm for quantum computing has further buoyed sentiment, even as investors weigh dilution and execution risks.

2026 Outlook and Factors to Watch

Looking ahead, QUBT’s 2026 performance will hinge on its ability to successfully integrate Luminar Semiconductor and translate expanded photonics capabilities into scalable production and recurring revenue. Vertical integration across TFLN-based components positions the company to deliver room-temperature quantum hardware for government, defense, and commercial markets, particularly as U.S. reshoring initiatives gain momentum.

Investors will closely monitor progress on photonic chip foundry operations, potential wins related to LiDAR assets, and commercialization timelines. Broader industry trends—including AI-driven demand for quantum solutions and optical interconnects—provide tailwinds, but competition from peers such as IonQ and Rigetti remains intense. Forecasted losses, with consensus EPS near -$0.26 for FY2026, underscore ongoing cash burn concerns despite recent capital raises.

Regulatory oversight of quantum technologies, especially those tied to national security, along with supply-chain execution, adds another layer of complexity. Ultimately, updates on partnerships, product demonstrations, and quarterly revenue contributions from acquired programs will serve as critical indicators of whether QUBT can convert strategic expansion into sustainable growth in this early-stage, high-potential sector.

Tickeron AI trading bot

Disclaimers and Limitations

Related Ticker: QUBT

QUBT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for QUBT turned positive on July 30, 2026. Looking at past instances where QUBT's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on QUBT as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

QUBT broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QUBT entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.261) is normal, around the industry mean (8.659). P/E Ratio (0.000) is within average values for comparable stocks, (39.987). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.623). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. QUBT's P/S Ratio (384.615) is slightly higher than the industry average of (70.563).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 28.4B. The market cap for tickers in the group ranges from -0.18 to 295.86B. DELL holds the highest valuation in this group at 295.86B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 9%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 36%. SCKT experienced the highest price growth at 418%, while WDC experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 57%. For the same stocks of the Industry, the average monthly volume growth was 84% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 53
SMR Rating: 79
Profit Risk Rating: 86
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
QUBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerProcessingHardware

Profile
Details
Industry
N/A
Address
No.5 Marine View Plaza
Phone
+1 703 436-2121
Employees
77
Web
https://www.quantumcomputinginc.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.